These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24899720)

  • 1. Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature.
    Caccamo A; De Pinto V; Messina A; Branca C; Oddo S
    J Neurosci; 2014 Jun; 34(23):7988-98. PubMed ID: 24899720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
    Caccamo A; Belfiore R; Oddo S
    Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance.
    Zhu Z; Yan J; Jiang W; Yao XG; Chen J; Chen L; Li C; Hu L; Jiang H; Shen X
    J Neurosci; 2013 Aug; 33(32):13138-49. PubMed ID: 23926267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice.
    Wang S; Zhou SL; Min FY; Ma JJ; Shi XJ; Bereczki E; Wu J
    Metab Brain Dis; 2014 Sep; 29(3):729-36. PubMed ID: 24682776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
    Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
    Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.
    Oliveira TG; Chan RB; Tian H; Laredo M; Shui G; Staniszewski A; Zhang H; Wang L; Kim TW; Duff KE; Wenk MR; Arancio O; Di Paolo G
    J Neurosci; 2010 Dec; 30(49):16419-28. PubMed ID: 21147981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits activation of AMPK-mTOR signaling pathway-induced Alzheimer's disease lesion in hippocampus of rats with type 2 diabetes mellitus.
    Sun Q; Wei LL; Zhang M; Li TX; Yang C; Deng SP; Zeng QC
    Int J Neurosci; 2019 Feb; 129(2):179-188. PubMed ID: 29962282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
    Wang C; Zhang X; Teng Z; Zhang T; Li Y
    Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
    Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
    Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism.
    Caccamo A; Maldonado MA; Majumder S; Medina DX; Holbein W; Magrí A; Oddo S
    J Biol Chem; 2011 Mar; 286(11):8924-32. PubMed ID: 21266573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
    Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
    PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease.
    Sun YX; Ji X; Mao X; Xie L; Jia J; Galvan V; Greenberg DA; Jin K
    J Alzheimers Dis; 2014; 38(2):437-44. PubMed ID: 23979023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
    Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW
    Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.